ArticleOncoTargets and therapy2020

Erratum: GRHL2 Acts as an Anti-Oncogene in Bladder Cancer by Regulating ZEB1 in Epithelial-Mesenchymal Transition (EMT) Process [Erratum].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.